A crackdown amid a social media craze
According to the South China Morning Post, Hong Kong's Department of Health said it seized vials of Elravie Re20 during inspections of four beauty premises on Friday and Tuesday. A 38-year-old woman was arrested in the operation.
Authorities classified the product as a “regulated product” under the Human Organ Transplant Ordinance and also as a pharmaceutical product. Several other related cases have been referred to the police, who confirmed they were following up.
The department is processing an exemption application for the product as a “regulated product”, but has received no application to register it as a pharmaceutical. Dr Fung Ying, the department's controller of regulatory affairs, warned that the product lacked clinical safety data and could pose public health risks.
From Korean clinics to smartphone screens
According to Humedix, its Korean distributor, Elravie Re20 contains human acellular dermal matrix derived from processed human tissue and is marketed as improving skin blemishes and pores. Some Korean clinics have even set up Chinese-language webpages promoting its anti-ageing effects.

















